MBS spends more than $40m a year on NCD drugs and overseas care

Antigua and Barbuda’s Medical Benefits Scheme (MBS) spends more than $40m each year on medications, mainly to treat non-communicable diseases (NCDs), and on overseas medical care not available locally.

Health Minister Sir Molwyn Joseph disclosed the figure while speaking at the opening of a new polyclinic on Thursday.

He said MBS spends about $25m annually on drugs through the OECD Drug Procurement Programme, which helps reduce costs, with most medications used to treat conditions such as diabetes. A further $15m is spent on sending patients overseas for specialist care.

Sir Molwyn warned that deaths linked to NCDs are rising, describing the growth in cases as “alarming”. He said lifestyle choices were a major factor and stressed the need for prevention through exercise and nutrition, supported by wider collaboration.

MBS Board Chairman Sir Heston Benjamin said the new polyclinic pharmacy was aimed at improving access to care, making services more convenient for patients.

Head of MBS Pharmaceutical Services Andre Howell said the facility reflects a changing health landscape, with greater focus on chronic illnesses such as heart disease, cancer, diabetes and respiratory conditions.

The ceremony ended with a ribbon-cutting by Sir Molwyn and Sir Lester Bird Medical Centre chief executive Keston Simon.

Advertise with the mоѕt vіѕіtеd nеwѕ ѕіtе іn Antigua!
We offer fully customizable and flexible digital marketing packages.
Contact us at [email protected]